SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
SI-BONE, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$19.66−0.02 (-0.10%)
Close on Oct 19, 2026
- Market cap
- $874.42M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
SI-BONE, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $191.08M | $158.42M | $130.62M | $98.75M | $82.74M | $68.12M | $61.84M | $50.14M | $43.35M | 95.1% | +20.6% |
| International | $9.85M | $8.76M | $8.27M | $7.66M | $7.41M | $5.27M | $5.46M | $5.24M | $4.63M | 4.9% | +12.4% |
From the segment and revenue-disaggregation notes of Si-Bone's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.